Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Combination chemotherapy

Sintilimab plus chemotherapy with or without bevacizumab biosimilar IBI305 in EGFR-mutated non-squamous NSCLC patients who progressed on EGFR TKI therapy: A China-based cost-effectiveness analysis

Juan Peng, Huiling Xu, Qiao Liu

Melatonin mitigates chemotherapy-induced small intestinal atrophy in rats and reduces cytotoxicity in murine intestinal organoids

Karsten Peters, Ada Lerma Clavero, [ ... ], Markus Sjöblom

Prognostic factors in clinical stage IIIA small cell lung cancer: An analysis of a population-based cancer registry in Taiwan

Sung-Chi Yu, Jing-Yang Huang, [ ... ], Bing-Yen Wang

Budget impact analysis of durvalumab consolidation therapy vs no consolidation therapy after chemoradiotherapy in stage III non–small cell lung cancer in the context of the Chilean health care system

Nicolás Armijo, Constanza Salas, [ ... ], Carlos Balmaceda

Efficacy and safety of concurrent immune checkpoint inhibitors combined with radiotherapy or chemoradiotherapy for advanced non-small cell lung cancer: A systematic review and single-arm meta-analysis

Ran Cui, Yun Li, [ ... ], Ou Jiang

Sex differences in prognosis factors in patients with lung cancer: A nationwide retrospective cohort study in Korea

Youn Huh, Yeo Ju Sohn, [ ... ], Ki Young Son

The efficacy and safety of immune-checkpoint inhibitors plus chemotherapy versus chemotherapy for non-small cell lung cancer: An updated systematic review and meta-analysis

Jing Kang, Jun Zhang, [ ... ], Mingxian Li

Clinical trials of R-(-)-gossypol (AT-101) in newly diagnosed and recurrent glioblastoma: NABTT 0602 and NABTT 0702

John B. Fiveash, Xiaobu Ye, [ ... ], Louis B. Nabors

Efficacy and safety profile of combining antiangiogenic agents with chemotherapy in patients with advanced malignant pleural mesothelioma: A systematic review and meta-analysis of randomized controlled trials

Wei Tian, Qian Guo, [ ... ], Rui Wang

Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: The CISLOW-study protocol

Anouk W. M. A. Schaeffers, Lot A. Devriese, [ ... ], Remco de Bree

Longitudinal measurements of neutrophil-to-lymphocyte ratio in nasopharyngeal cancer treated with concurrent chemoradiotherapy

Pooriwat Muangwong, Nontiya Homkham, [ ... ], Imjai Chitapanarux

Prognostic value of neoadjuvant therapy for resectable and borderline resectable pancreatic cancer: A meta-analysis of randomized controlled trials

Shangtong Liu, Hui Li, Yuhui Xue, Liang Yang

A trial-based cost-utility analysis of sugemalimab vs. placebo as consolidation therapy for unresectable stage III NSCLC in China

Wei Li, Li Wan

Advertisement

Create a weekly email alert for: Combination chemotherapy

You can change these options by clicking profile then "Alerts and Notifications"